MEDTRONIC HEART VALVES DIVISION EVOLUT PRO PLUS DCS; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV
|
Back to Search Results |
|
Model Number D-EVPROP34 |
Device Problems
Failure to Advance (2524); Material Protrusion/Extrusion (2979)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 03/19/2024 |
Event Type
malfunction
|
Manufacturer Narrative
|
Continuation of d10: product id evproplus-34 (serial: (b)(6)); product type: 0195-heart valves.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Event Description
|
Medtronic received information that during implant of this transcatheter bioprosthetic valve, the right femoral artery was chosen as the access vessel.A pre-implant balloon aortic valvuloplasty (bav) was performed using a 23 mm non-medtronic vacs ii balloon.The guidewire selected for this case was a non-medtronic lunderquist doublecurved wire.After accessing the groin, when passing the delivery catheter system (dcs), the dcs was not able to advance further than the common iliac artery due to circular calcification.Attempts were made to pass the vessel.A 8 mm percutaneous transluminal angioplasty (pta) balloon was inflated to dilate the vessel.Following the dilation, the dcs was still not able to be advanced.Per the physician request, the access was moved to the left groin.On the left side however, the same issues occurred.Advancing past the common iliac artery was not possible due to the calcification.A pre-dilation of the vessel was made using a 20 fr sentrant sheath.During the dilation, the loader noticed that the capsule metal layer had poked through the capsule "pu" layer.The entire system was discarded.A replacement valve was loaded onto a new system and was able to be deployed successfully.No adverse patient effects were reported.
|
|
Manufacturer Narrative
|
Updated b5.Updated h6.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Event Description
|
Additional information was received which reported that a 30 minute procedural delay occurred.
|
|
Search Alerts/Recalls
|
|
|